The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Golden State Medical Supply, Inc. to distribute methocarbamol tablets. The contract has a potential value of $25.5 million over a base year and four option years.
Golden State Medical Supply will supply methocarbamol tablets in four package sizes and strengths to the VA and other government agencies through March 2024. The estimated annual quantities provided in the pre-solicitation notice were 56,065 bottles of 500mg tablets in 100 count bottles, 99,068 bottles of 500mg tablets in 500 count bottles, 23,307 bottles of 750mg tablets in 100 count bottles, and 63,331 bottles of 750mg tablets in 500 count bottles. Task orders will be issued against the contract on an as-needed basis to supply VA hospitals, Department of Defense medical treatment facilities, and other sites with the generic pharmaceutical.
The originating opportunity had no set-aside designations and sought market research information from suppliers regarding their ability to meet the key requirements for the pharmaceutical distribution contract, which included providing all package strengths and sizes commercially, filling initial orders of up to 30% of annual quantities, and delivering to the VA pharmaceutical prime vendor within 45 days of award. The award was issued to Golden State Medical Supply, a subsidiary of Gsms Inc. that distributes pharmaceuticals and medical supplies to government customers through indefinite delivery vehicles and federal supply schedules.
Generated 3/14/24, 9:37 AM